Hauser Reports Fiscal 2002 First Quarter Financial Results


BOULDER, Colo., Aug. 13, 2001 (PRIMEZONE) -- Hauser, Inc. (OTCBB:HAUS) today reported its financial results for the fiscal 2002 first quarter ended June 30, 2001.

For the fiscal 2002 first quarter, net loss narrowed to $618,000, or $0.12 per share, from a net loss in the corresponding quarter a year ago of $1.9 million, or $0.40 per share. Loss from operations was $178,000, compared with loss from operations of $2.0 million in the same quarter a year ago. Total revenues were $15.8 million, compared with total revenues of $21.7 million in the quarter ended June 30, 2000.

Kenneth Cleveland, president and chief executive officer, said, "Our results reflect the excellent progress we have made reducing costs and operating more efficiently. We will continue to build upon our improving financial performance and strong science capabilities."

Hauser, a Customer Connected(SM) company headquartered in Boulder, Colorado, is a leading supplier of herbal extracts and nutritional supplements. The company also provides interdisciplinary laboratory testing services, chemical engineering services, and contract research and development. The company's products and services are principally marketed to the pharmaceutical, dietary supplement and food ingredient businesses. Hauser's business units include: Botanicals International Extracts, Hauser Laboratories, Shuster Laboratories and ZetaPharm.


 HAUSER, INC.
 CONSOLIDATED STATEMENTS OF OPERATIONS - Unaudited
 
                                        Three Months     Three Months 
                                            Ended            Ended
                                        June 30, 2001   June 30, 2000
                                        ------------     ------------
 REVENUES:
    Dietary Supplements                 $  9,411,000     $ 12,654,000
    Fine chemicals                         1,606,000        4,418,000
    Technical services                     4,733,000        4,265,000
    Pharmaceuticals                             --            403,000
                                        ------------     ------------
      Total revenues                      15,750,000       21,740,000
                                        ------------     ------------
                                                     
 COST OF REVENUES:                                    
    Dietary Supplements                    7,400,000       11,781,000
    Fine chemicals                         1,331,000        4,385,000
    Technical services                     3,577,000        3,346,000
    Pharmaceuticals                             --               --
                                        ------------     ------------
      Total cost of revenues              12,308,000       19,512,000
                                        ------------     ------------
                                                      
 GROSS PROFIT                              3,442,000        2,228,000
                                        ------------     ------------
                                                      
 OPERATING EXPENSES:                                  
    Research and development                 671,000          533,000
    Sales and marketing                      761,000          848,000
    General and administrative             2,188,000        2,828,000
                                        ------------     ------------
      Total operating expenses             3,620,000        4,209,000
                                        ------------     ------------
 LOSS FROM OPERATIONS                       (178,000)      (1,981,000)
                                        ------------     ------------
                                                      
 OTHER INCOME (EXPENSE):                              
    Interest and other income                  5,000           17,000
    Interest expense                        (445,000)        (587,000)
    Net gain from sale of assets                --            627,000
                                        ------------     ------------
      Total other income (expense)          (440,000)          57,000
                                        ------------     ------------
                                                    
 LOSS BEFORE INCOME TAX                     (618,000)      (1,924,000)
                                                      
 INCOME TAX EXPENSE                             --               --
                                        ------------     ------------
 NET LOSS                               $   (618,000)    $ (1,924,000)
                                        ============     ============
                                                      
 LOSS PER SHARE BASIC AND DILUTED       $      (0.12)    $      (0.40)
                                        ============     ============
                                                      
 WEIGHTED AVERAGE SHARES OUTSTANDING                  
   BASIC AND DILUTED                       5,205,582        4,818,372
                                        ============     ============
                                                      
                                                      
 HAUSER, INC.
 CONSOLIDATED BALANCE SHEETS - Unaudited
 
                                              June 30,     March 31,
 ASSETS                                         2001         2001
                                            -----------   -----------
 CURRENT ASSETS:
    Cash and cash equivalents               $   785,000   $   616,000
    Accounts receivable, net                 12,442,000    12,272,000
    Inventory, at lower of cost or market     9,719,000     9,802,000
    Prepaid expenses and other                1,064,000       928,000
                                            -----------   -----------
      Total current assets                   24,010,000    23,618,000
                                            -----------   -----------

 PROPERTY AND EQUIPMENT:
      Property and equipment, net            12,149,000    12,699,000
                                            -----------   -----------

 OTHER ASSETS:
    Goodwill, net                               892,000       948,000
    Deposits and other                          573,000       574,000
                                            -----------   -----------
                                            $37,624,000   $37,839,000
                                            ===========   ===========

 LIABILITIES AND STOCKHOLDERS' EQUITY

 CURRENT LIABILITIES:
    Accounts payable                        $ 2,652,000   $ 2,833,000
    Current portion of long-term debt        18,742,000    18,790,000
    Other current liabilities                 8,409,000     8,265,000
                                            -----------   -----------
      Total current liabilities              29,803,000    29,888,000
                                            -----------   -----------

 LONG-TERM DEBT                                  19,000        36,000
                                            -----------   -----------

 NOTE PAYABLE TO RELATED PARTY                2,734,000     2,705,000
                                            -----------   -----------

 STOCKHOLDERS' EQUITY:                        5,068,000     5,210,000
                                            -----------   -----------
                                            $37,624,000   $37,839,000
                                            ===========   ===========


            

Kontaktdaten